In contrast, administering CCL20 via intratumoral injection in subcutaneous HCC mouse models restored tumor growth, reduced the CD8+ T cell infiltration, increased the frequency of CD4+CD25+Foxp3+ Tregs and CCR6+ Tregs in shGal1 tumors (Figure S4, Supporting Information). Here, CCL20 is linked to hepatocellular carcinoma.